Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 95 for “"SHP2"”.

  1. Potential therapeutic target for DMD-associated cardiomyopathy : SHP2

    … region 2 domain-containing phosphatase-2 (SHP2) inhibition may have cardioprotective effects. SHP2 is a protein tyrosine phosphatase that dephosphorylates proteins involved in several cellular processes. We investigated the potential beneficial effects of SHP2 inhibition through analysis of …

    missouri Repository record for Potential therapeutic target for DMD-associated cardiomyopathy : SHP2 (opens in a new tab)

  2. The development of orthosteric inhibitors of SHP2 phosphatase

    … in the regulation of cellular functions, and SHP2 phosphatase is a member of the non-receptor protein tyrosine phosphatase family of PTPs. As SHP2 is a protein associated with a variety of cancer-related diseases and is a potential immunomodulator, controlling SHP2 activity has important …

    fu-berlin Repository record for The development of orthosteric inhibitors of SHP2 phosphatase (opens in a new tab)

  3. Shp2 functions in postnatal skeletal muscle growth and regeneration

    Shp2 is a tyrosine phosphatase that mediates signals provided by many tyrosine kinase receptors. The experiments performed in this study revealed an important role for Shp2 in early postnatal muscle growth and adult muscle regeneration. Shp2 mutation in fetal myogenic progenitors and adult …

    fu-berlin Repository record for Shp2 functions in postnatal skeletal muscle growth and regeneration (opens in a new tab)

  4. The GAB2/SHP2 Pathway in BCR-ABL1-Induced Hematopoietic Neoplasia

    … role of the protein-tyrosine phosphatase (PTP) SHP2 in the initiation and/or maintenance of CML and BCR- ABL1+ B-ALL. I found that SHP2 is required for initiation and maintenance of CML, consistent with its essentiality in normal hematopoietic stem cells (HSCs). In BCR-ABL1+ B-ALL, SHP2 is …

    toronto-retro Repository record for The GAB2/SHP2 Pathway in BCR-ABL1-Induced Hematopoietic Neoplasia (opens in a new tab)

  5. Fragment-based screening of the oncogenic protein tyrosine phosphatase SHP2

    … The cytoplasmic protein tyrosine phosphatase SHP2, encoded by the PTPN11 gene, plays a central role in the activation of downstream signalling events at multiple growth factor and cytokine receptors, and was the first oncogenic protein tyrosine phosphatase to be discovered. Aberrant SHP2 …

    birmingham Download PDF for Fragment-based screening of the oncogenic protein tyrosine phosphatase SHP2 (opens in a new tab)

  6. Structural characterization of the protein tyrosine phosphatase Shp2 in solution

    … The Protein Tyrosine Phosphatase (PTP) Shp2 is a highly conserved enzyme involved in a myriad of cellular processes including growth, differentiation and apoptosis. Shp2 is multi-domain protein composed of two SH2 domains in tandem, a PTP catalytic domain and a C-terminal tail containing …

    birmingham Download PDF for Structural characterization of the protein tyrosine phosphatase Shp2 in solution (opens in a new tab)

  7. The intramolecular domain interactions and phosphatase activation mechanisms of Shp2

    Shp2 (Src Homology 2 Domain-containing Protein Tyrosine Phosphatase 2) is a pivotal player in various signaling pathways in response to growth factors. It contains two SH2 domains (N-SH2 and C-SH2), a phosphatase catalytic domain and a C-terminal tail containing two tyrosyl phosphorylation sites. …

    uiuc Repository record for The intramolecular domain interactions and phosphatase activation mechanisms of Shp2 (opens in a new tab)

  8. SHP2 Inhibition as a Therapeutic Strategy to Target High-risk Neuroblastoma

    … The PTPN11-encoded tyrosine phosphatase SHP2 is an activator of the RAS pathway, and we and others have shown that pharmacologic inhibition of SHP2 suppresses the growth of various tumor types harboring KRAS mutations such as pancreatic and lung cancers. Here, we report inhibition of …

    toronto-retro Repository record for SHP2 Inhibition as a Therapeutic Strategy to Target High-risk Neuroblastoma (opens in a new tab)

  9. SHP2/PTPN11 Protein-Tyrosine Phosphatase Promotes Mast Cell Homeostasis and Systemic Mastocytosis

    … Src Homology 2 domain containing phosphatase-2 (SHP2 or PTPN11) is a protein tyrosine phosphatase that promotes cell proliferation, survival and motility in multiple pathways and cell types. To study SHP2 function in MCs, we generated novel MC-specific Shp2 knock-out (KO) mice (MC-shp2 KO). These …

    queens Repository record for SHP2/PTPN11 Protein-Tyrosine Phosphatase Promotes Mast Cell Homeostasis and Systemic Mastocytosis (opens in a new tab)

  10. Targeting the Protein Tyrosine Phosphatase, SHP2, and PI3K in FLT3-ITD+ Leukemia

    … myeloid leukemia (AML). We hypothesized that Shp2 interacts with FLT3-ITD via protein complexes at tyrosine (Y) 768, 955, and/or 969 and that Shp2 and PI3K work cooperatively to promote FLT3-ITD-induced leukemogenesis. Consistently, mutation of N51-FLT3 tyrosine 768 to phenylalanine reduced …

    iupui Repository record for Targeting the Protein Tyrosine Phosphatase, SHP2, and PI3K in FLT3-ITD+ Leukemia (opens in a new tab)

  11. Effects of mutant SHP2 expression on heart function in Duchenne muscular dystrophy

    … SH2 domain-containing tyrosine phosphatase 2 (SHP2) plays a regulatory role in several cell signaling events. Work from our lab has discovered that a loss-offunction mutation in SHP2 improves heart function after transverse aortic banding. I hypothesized that expression of a loss-of-function …

    missouri Repository record for Effects of mutant SHP2 expression on heart function in Duchenne muscular dystrophy (opens in a new tab)

  12. Sulforaphane-mediated inhibition of SHP2 as a potential pharmacotherapy for Noonan syndrome

    … the non-receptor protein-tyrosine phosphatase, SHP2, as a target of SFN. SFN is intrinsically unstable at room temperature, therefore, a chemically stabilised variant developed by Evgen Pharmaceuticals (UK) known as Sulforadex (SFX-01), was used in subsequent experiments. Using a commercially …

    kings Repository record for Sulforaphane-mediated inhibition of SHP2 as a potential pharmacotherapy for Noonan syndrome (opens in a new tab) Download PDF for Sulforaphane-mediated inhibition of SHP2 as a potential pharmacotherapy for Noonan syndrome (opens in a new tab)

  13. Funktionelle Analyse des Shp2-Gens in der Entwicklung der Muskulatur der Maus

    … Arbeit wurde gezeigt, dass die Mutation des Shp2flox Allels in Mäusen, in denen die Cre-Rekombinase unter Kontrolle des Pax7-Promoters exprimiert wurde, zu einem Verlust des Shp2 Proteins in Myoblasten zum Zeitpunkt E14 führte (coShp2 Mutante). Dieser Verlust resultierte während der …

    fu-berlin Repository record for Funktionelle Analyse des Shp2-Gens in der Entwicklung der Muskulatur der Maus (opens in a new tab)

  14. Die Tyrosinphosphatase Shp2 agiert unterhalb der Rezeptor-Tyrosinkinase Ret in der embryonalen Nierenentwicklung

    Die Protein-Tyrosinphosphatase Shp2 ist ein zytoplasmatisches Enzym, welches unterhalb einer Reihe von Rezeptor-Tyrosinkinasen, Hormon- oder Zytokinrezeptoren als positiver Signalüberträger agiert. Ein konditionelle Shp2- Deletion wurde im Epithel des Wolff´schen Gangs und im Ureterepithel mit …

    fu-berlin Repository record for Die Tyrosinphosphatase Shp2 agiert unterhalb der Rezeptor-Tyrosinkinase Ret in der embryonalen Nierenentwicklung (opens in a new tab)

  15. Exploring the mechanism of SHP2 and EGFR/HER2 cooperation in breast cancer cell signaling

    … 2-containing protein tyrosine phosphatase 2 (SHP2) has been established as a critical mediator of cancer-related cell signaling downstream of receptor tyrosine kinases like EGFR and HER2. As such, targeting of SHP2 is being recognized as a potentially viable therapeutic option in HER2-positive …

    wvu Repository record for Exploring the mechanism of SHP2 and EGFR/HER2 cooperation in breast cancer cell signaling (opens in a new tab)

  16. Shp2 deletion in post-migratory neural crest cells results in impaired cardiac sympathetic innervation

    … of Src homology protein tyrosine phosphatase 2 (Shp2). Shp2 is a ubiquitously expressed non-receptor phosphatase involved in a variety of cellular functions including survival, proliferation, and differentiation. We targeted Shp2 in post-migratory neural crest (NC) lineages using our novel …

    iupui Repository record for Shp2 deletion in post-migratory neural crest cells results in impaired cardiac sympathetic innervation (opens in a new tab)

  17. The Protein Tyrosine Phosphate, SHP2, Functions in Multiple Cellular Compartments in FLT3-ITD+ Leukemia

    … shown that the protein tyrosine phosphatase, Shp2, associates physically FLT3-ITD at tyrosine 599 (Y599) and positively regulates aberrant STAT5 activation and leukemogenesis. We also demonstrated that genetic disruption of Ptpn11, the gene encoding Shp2, increased malignancy specific survival …

    iupui Repository record for The Protein Tyrosine Phosphate, SHP2, Functions in Multiple Cellular Compartments in FLT3-ITD+ Leukemia (opens in a new tab)

  18. Novel Roles of the Protein Tyrosine Phosphatase SHP2 in Non-small Cell Lung Cancer

    … non-transmembrane protein tyrosine phosphatase SHP2. SHP2 is expressed ubiquitously in cells, and plays an important role in cancer. Unlike most phosphatases, SHP2 positively regulates several signaling pathways including the Ras/MAPK and Src signaling pathways and acts as a proto-oncogene. SHP2 …

    usf Repository record for Novel Roles of the Protein Tyrosine Phosphatase SHP2 in Non-small Cell Lung Cancer (opens in a new tab)

  19. Immunomodulatory impact of PTPN11/SHP2-based vertical RAS-MAPK pathway inhibition in pancreatic cancer

    … tyrosine phosphatase non-receptor 11 (PTPN11/SHP2) is a critical upstream mediator of RAS-MAPK signaling and a central node in adaptive resistance mechanisms evolving with RAS and MEK/ERK inhibition. Accordingly, clinical trials are currently evaluating allosteric SHP2 inhibitors in vertical …

    freiburg-diss Repository record for Immunomodulatory impact of PTPN11/SHP2-based vertical RAS-MAPK pathway inhibition in pancreatic cancer (opens in a new tab)

Page 1 of 5